171 related articles for article (PubMed ID: 12007958)
1. Activation of the nuclear transcription factor kappaB (NFkappaB) and differential gene expression in U87 glioma cells after exposure to the cytoprotector amifostine.
Kataoka Y; Murley JS; Khodarev NN; Weichselbaum RR; Grdina DJ
Int J Radiat Oncol Biol Phys; 2002 May; 53(1):180-9. PubMed ID: 12007958
[TBL] [Abstract][Full Text] [Related]
2. Differential activation of nuclear transcription factor kappaB, gene expression, and proteins by amifostine's free thiol in human microvascular endothelial and glioma cells.
Grdina DJ; Murley JS; Kataoka Y; Calvin DP
Semin Radiat Oncol; 2002 Jan; 12(1 Suppl 1):103-11. PubMed ID: 11917294
[TBL] [Abstract][Full Text] [Related]
3. Delayed radioprotection by NFkappaB-mediated induction of Sod2 (MnSOD) in SA-NH tumor cells after exposure to clinically used thiol-containing drugs.
Murley JS; Kataoka Y; Cao D; Li JJ; Oberley LW; Grdina DJ
Radiat Res; 2004 Nov; 162(5):536-46. PubMed ID: 15624308
[TBL] [Abstract][Full Text] [Related]
4. Delayed radioprotection by nuclear transcription factor kappaB -mediated induction of manganese superoxide dismutase in human microvascular endothelial cells after exposure to the free radical scavenger WR1065.
Murley JS; Kataoka Y; Weydert CJ; Oberley LW; Grdina DJ
Free Radic Biol Med; 2006 Mar; 40(6):1004-16. PubMed ID: 16540396
[TBL] [Abstract][Full Text] [Related]
5. Interaction of amifostine and ionizing radiation on transcriptional patterns of apoptotic genes expressed in human microvascular endothelial cells (HMEC).
Khodarev NN; Kataoka Y; Murley JS; Weichselbaum RR; Grdina DJ
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):553-63. PubMed ID: 15380592
[TBL] [Abstract][Full Text] [Related]
6. Activation of NFkappaB and MnSOD gene expression by free radical scavengers in human microvascular endothelial cells.
Murley JS; Kataoka Y; Hallahan DE; Roberts JC; Grdina DJ
Free Radic Biol Med; 2001 Jun; 30(12):1426-39. PubMed ID: 11390188
[TBL] [Abstract][Full Text] [Related]
7. Cytoprotection by WR-1065, the active form of amifostine, is independent of p53 status in human malignant glioma cell lines.
Kataoka Y; Murley JS; Patel R; Grdina DJ
Int J Radiat Biol; 2000 May; 76(5):633-9. PubMed ID: 10866285
[TBL] [Abstract][Full Text] [Related]
8. Manganese superoxide dismutase (SOD2)-mediated delayed radioprotection induced by the free thiol form of amifostine and tumor necrosis factor alpha.
Murley JS; Kataoka Y; Baker KL; Diamond AM; Morgan WF; Grdina DJ
Radiat Res; 2007 Apr; 167(4):465-74. PubMed ID: 17388698
[TBL] [Abstract][Full Text] [Related]
9. Relationships between cytoprotection and mutation prevention by WR-1065.
Grdina DJ; Murley JS; Kataoka Y; Epperly W
Mil Med; 2002 Feb; 167(2 Suppl):51-3. PubMed ID: 11873516
[TBL] [Abstract][Full Text] [Related]
10. Delayed cytoprotection after enhancement of Sod2 (MnSOD) gene expression in SA-NH mouse sarcoma cells exposed to WR-1065, the active metabolite of amifostine.
Murley JS; Kataoka Y; Weydert CJ; Oberley LW; Grdina DJ
Radiat Res; 2002 Jul; 158(1):101-9. PubMed ID: 12071809
[TBL] [Abstract][Full Text] [Related]
11. Repression of c-myc gene expression by the thiol and disulfide forms of the cytoprotector amifostine.
Liu SC; Murley JS; Woloschak G; Grdina DJ
Carcinogenesis; 1997 Dec; 18(12):2457-9. PubMed ID: 9450496
[TBL] [Abstract][Full Text] [Related]
12. Selective exclusion by the polyamine transporter as a mechanism for differential radioprotection of amifostine derivatives.
Quiñones HI; List AF; Gerner EW
Clin Cancer Res; 2002 May; 8(5):1295-300. PubMed ID: 12006551
[TBL] [Abstract][Full Text] [Related]
13. Maintenance of manganese superoxide dismutase (SOD2)-mediated delayed radioprotection induced by repeated administration of the free thiol form of amifostine.
Murley JS; Nantajit D; Baker KL; Kataoka Y; Li JJ; Grdina DJ
Radiat Res; 2008 May; 169(5):495-505. PubMed ID: 18439041
[TBL] [Abstract][Full Text] [Related]
14. Effects of WR-2721 (amifostine) and its metabolite WR-1065 on the antiproliferative activity of chemotherapeutic agents on neuroblastoma cells in vitro.
Fulda S; Oster W; Berthold F
Anticancer Drugs; 1997 Jan; 8(1):34-41. PubMed ID: 9147609
[TBL] [Abstract][Full Text] [Related]
15. WR-1065, an active metabolite of the cytoprotector amifostine, affects phosphorylation of topoisomerase II alpha leading to changes in enzyme activity and cell cycle progression in CHO AA8 cells.
Murley JS; Constantinou A; Kamath NS; Grdina DJ
Cell Prolif; 1997; 30(6-7):283-94. PubMed ID: 9451419
[TBL] [Abstract][Full Text] [Related]
16. Enhancement of fotemustine (Muphoran) cytotoxicity by amifostine in malignant melanoma cell lines.
Merlin JL; Marchal S; Ramacci C; Berlion M; Poullain MG
Anticancer Drugs; 2002 Feb; 13(2):141-7. PubMed ID: 11901306
[TBL] [Abstract][Full Text] [Related]
17. The radioprotective agent, amifostine, suppresses the reactivity of intralysosomal iron.
Yu Z; Eaton JW; Persson HL
Redox Rep; 2003; 8(6):347-55. PubMed ID: 14980067
[TBL] [Abstract][Full Text] [Related]
18. WR-1065, the active metabolite of amifostine, mitigates radiation-induced delayed genomic instability.
Dziegielewski J; Baulch JE; Goetz W; Coleman MC; Spitz DR; Murley JS; Grdina DJ; Morgan WF
Free Radic Biol Med; 2008 Dec; 45(12):1674-81. PubMed ID: 18845240
[TBL] [Abstract][Full Text] [Related]
19. Interaction of cultured mammalian cells with WR-2721 and its thiol, WR-1065: implications for mechanisms of radioprotection.
Purdie JW; Inhaber ER; Schneider H; Labelle JL
Int J Radiat Biol Relat Stud Phys Chem Med; 1983 May; 43(5):517-27. PubMed ID: 6303973
[TBL] [Abstract][Full Text] [Related]
20. In vitro antioxidant properties of amifostine (WR-2721, Ethyol).
Marzatico F; Porta C; Moroni M; Bertorelli L; Borasio E; Finotti N; Pansarasa O; Castagna L
Cancer Chemother Pharmacol; 2000; 45(2):172-6. PubMed ID: 10663633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
